Pg 47 | Cover Story
Pg 47 | Cover Story
FEATURING
FDA accepts Merck's sNDA for WELIREG to treat advanced PPGL, with a target decision by May 26, 2025.
MAGAZINE ARTICLE by Mrudula Kulkarni
Roche’s PATHWAY HER2 test now identifies HER2-ultralow breast cancer patients eligible for ENHERTU treatment.
MAGAZINE ARTICLE by Simantini Singh Deo
Illuccix secures European marketing approval, advancing prostate cancer imaging standards.
MAGAZINE ARTICLE by Mrudula Kulkarni
PM Modi hails Genome India Project for revolutionizing India's healthcare and genetic research.
MAGAZINE ARTICLE by Simantini Singh Deo
Elutia unveils EluPro™, a biomatrix innovation for safer, infection-free implantable devices.
MAGAZINE ARTICLE by Mrudula Kulkarni
Enhanc3D Genomics launches 3D Multi-Omic solutions to revolutionize precision drug discovery.
MAGAZINE ARTICLE by Mrudula Kulkarni
Genenta deepens AGC partnership for dedicated cell therapy production, advancing trials for GBM and mRCC.
MAGAZINE ARTICLE by Priyanka Patil
Vaxcyte's VAX-31 enters the second stage of Phase 2 trials in infants, aiming to broaden protection against pneumococcal disease.
MAGAZINE ARTICLE by Simantini Singh Deo
Amylyx names Dan Monahan as Chief Commercial Officer to lead avexitide commercialization for PBH treatment.
MAGAZINE ARTICLE by Simantini Singh Deo
Serina appoints Karen J. Wilson to the board, leveraging her 30+ years of biotech finance and leadership expertise.
MAGAZINE ARTICLE by Mrudula Kulkarni
Kilitch Drugs’ Bhavin Mehta named Vice-Chairman of Pharmexcil to boost India's pharmaceutical exports.
MAGAZINE ARTICLE by Mrudula Kulkarni
Julie Kim to lead Takeda as CEO from June 2026, succeeding Christophe Weber after his years of leadership.
MAGAZINE ARTICLE by Mrudula Kulkarni
Innovent and Roche partner to advance IBI3009, a DLL3 ADC for small-cell lung cancer, with Phase 1 trials underway.
MAGAZINE ARTICLE by Simantini Singh Deo
Variant Bio and Novo Nordisk partner to uncover genetic insights for new metabolic disease treatments.
MAGAZINE ARTICLE by Priyanka Patil
GSK announces the acquisition of IDRx, including lead molecule IDRX-42, a highly selective KIT TKI for gastrointestinal stromal tumors.
MAGAZINE ARTICLE by Mrudula Kulkarni
BioMed X and Merck successfully complete an oncology project, paving the way for new precision cancer therapies.
MAGAZINE ARTICLE by Mrudula Kulkarni